nonalcoholic%20fatty%20liver%20disease
NONALCOHOLIC FATTY LIVER DISEASE

Nonalcoholic fatty liver disease is having excessive hepatic fat (in the form of triglycerides) accumulation not due to excessive alcohol consumption or other secondary causes.

It is considered as a hepatic manifestation of metabolic syndrome.

Progression of nonalcoholic fatty liver disease is variable.

Drug Information
Shine Hepavite
calcium pantothenate + cyanocobalamin + nicotinami...

Indication: Adjuvant treatment of chronic liver disease, liver cirrhosis, fatty liver & intoxication by hepatotoxic su...

Shine Hepavite Forte
calcium pantothenate + nicotinamide + pyridoxine h...

Indication: Adjuvant treatment of chronic liver diseases, liver cirrhosis, fatty liver & intoxication by hepatotoxic s...

Simepar
calcium pantothenate + nicotinamide + silymarin + ...

Indication: Toxic & inflammatory liver disorders. Adjuvant in chronic liver disease.

Livolin Forte
nicotinamide + phospholipids + vitamin B1 + vitami...
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
New drug application approved by US FDA as of 01 - 15 September 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.